Clinical Trials Logo

Filter by:
NCT ID: NCT05884255 Recruiting - Clinical trials for Advanced Gastroenteropancreatic Neuroendocrine Tumor

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Start date: July 6, 2023
Phase: Phase 3
Study type: Interventional

The study is being conducted to evaluate the efficacy, and safety of Lutetium (177Lu) Oxodotreotide Injection in Subjects With advanced gastrointestinal pancreatic neuroendocrine tumors.

NCT ID: NCT05884008 Recruiting - Clinical trials for Coronary Artery Disease

Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I

RECOGNIZE-I
Start date: May 1, 2023
Phase:
Study type: Observational

This study is a multicenter, retrospective imaging study. The study intends to retrospectively enroll patients with acute myocardial infarction who had received coronary CTA in a certain time-window before this event. All coronary CTA will be analyzed by anatomic, functional and radiomic analysis, assisted by artificial intelligence. The purpose of this study is to establish a coronary artery disease risk stratification system by coronary CTA.

NCT ID: NCT05883865 Recruiting - Clinical trials for Severe Hypertriglyceridemia During Pregnancy

Safety Study of Fenofibrate During Pregnancy

Start date: June 1, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the safety of fenofibrate in severe hypertriglyceridemia pregnant women.

NCT ID: NCT05883852 Recruiting - Clinical trials for HER2 Positive Early Breast Cancer

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

Start date: June 7, 2023
Phase: Phase 3
Study type: Interventional

compare the efficacy and safety of TCbHP and EC-THP regimen in HER2-positive breast cancer patients

NCT ID: NCT05883774 Not yet recruiting - Clinical trials for Generalized Anxiety Disorder

Effects of rTMS on the Anxiety State of Older Patients With GAD

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of low-frequency repetitive transcranial magnetic stimulation on anxiety state in older patients with generalized anxiety disorder.

NCT ID: NCT05883709 Not yet recruiting - Clinical trials for Diffuse Large B-cell Lymphoma

A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL

Start date: July 1, 2023
Phase:
Study type: Observational

To evaluate the real-world efficacy of Tafasitamab combined with Lenalidomide base regimen in patients with relapsed or refractory DLBCL, with objective response rate as the primary end point.

NCT ID: NCT05883683 Not yet recruiting - Clinical trials for Recurrent Colorectal Carcinoma

Molecular Study and Precision Medicine for Colorectal Cancer

MSPM
Start date: July 1, 2023
Phase:
Study type: Observational

Researchers collect specimens from advanced or recurrent colorectal cancer (CRC) patients to conduct molecular profiling and establish tumor organoids (PDOs)/ patient-derived xenografts (PDXs). The aim of this study is to identify clinical actionable targets and predict in vivo response of the tumor to targeted drugs by using PDOs/ PDXs. And the above-mentioned studies will provide the patients with potential personalized cancer treatment options.

NCT ID: NCT05883670 Recruiting - Cervical Cancer Clinical Trials

Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer

Start date: March 9, 2023
Phase:
Study type: Observational

This study is a Prospective, Multicenter, non-interventive Real-world Study to evaluate the efficacy and safety of the treatment of Serplulimab in patients with Advanced,Recurrent and Metastatic Cervical Cancer. Approximately 118 eligible subjects are planned to be enrolled across all sites.

NCT ID: NCT05883592 Not yet recruiting - Aortic Dissection Clinical Trials

A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System

Start date: May 2023
Phase:
Study type: Observational

To evaluate aortic remodeling of Fabulous thoracic aortic stent system in the treatment of acute and subacute Stanford type B aortic dissection (the changes of aortic diameter, cross-sectional area,and volume of true lumen, false lumen and total aorta in different aoritc levels, and false lumen thrombosis in different aoritc levels), and splanchnic artery perfusion.

NCT ID: NCT05883306 Completed - Healthy Subjects Clinical Trials

Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

Start date: June 30, 2022
Phase: Phase 1
Study type: Interventional

To assess absorption, metabolism and excretion of [14C]-LXI-15028 in Chinese healthy male Subjects following a single oral dose of [14C]LXI-15028 suspension.